Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Net Cash Flow came in at $24.5 million in Q1 2026, up 1086.51% YoY from $2.1 million in Q1 2025, and down 71.84% on a QoQ basis from $87.0 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Net Cash Flow (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of Net Cash Flow data on file, last reported at $24.5 million in Q1 2026.
- Quarterly Net Cash Flow rose 1086.51% year-over-year to $24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.0 million (up 1705.97% YoY) and the FY2025 annual result came in at $13.5 million, up 282.71% from the prior year.
- Net Cash Flow declined to $24.5 million in Q1 2026, from $87.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $87.0 million in Q4 2025 to a low of -$3.1 million in Q3 2024.
- A 5-year average of $7.0 million and a median of -$1.1 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 24095.05% — and 2025, when it jumped 7272.57%.
- Tracing CNTN's Net Cash Flow over 5 years: stood at -$1.1 million in 2022, then soared by 859.23% to $8.2 million in 2023, then plunged by 114.71% to -$1.2 million in 2024, then jumped by 7272.57% to $87.0 million in 2025, then plunged by 71.84% to $24.5 million in 2026.
- The last three Net Cash Flow figures came in at $24.5 million (Q1 2026), $87.0 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | -3.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.71 Mn |
| Mar 31, 2026 | 24.50 Mn |
| Dec 31, 2025 | 87.01 Mn |
| Sep 30, 2025 | 5.36 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -531,463.00 |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | 334,825.00 |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -1.09 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | 11.12 Mn |
| Dec 31, 2021 | -40,739.00 |
| Sep 30, 2021 | 15,824.00 |